指南与共识

CoMI:用于组织特异性基因标签的共识互信息方法

CoMI: consensus mutual information for tissue-specific gene signatures.
指南 / 共识 · BMC Bioinformatics · 2022-04-19
一句话结论CoMI方法可识别具有组织特异性的基因标签,在胶质母细胞瘤中识别出50基因标签将患者分为高、低风险组(log-rank p=0.006)。

该研究提出共识互信息(CoMI)方法分析多癌种组学数据,识别差异表达基因以反映癌症相关和组织特异性特征。CoMI在多种癌症中识别出细胞生长与死亡相关基因,在LIHC中识别出外源物生物降解与代谢相关基因,在GBM中识别出神经系统相关基因。在GBM中,CoMI识别出50基因标签有效区分高、低风险患者(log-rank p=0.006),用于诊断和预后。作者认为CoMI有助于分析组学数据并发现疾病基因标签。

要点

  • CoMI方法可识别具有组织特异性的基因标签,用于癌症诊断和预后分析。
  • 在GBM中,CoMI识别出50基因标签将患者分为高、低风险组(log-rank p=0.006)。
  • CoMI在多种癌症中识别出细胞生长与死亡相关基因,在LIHC中识别出外源物生物降解与代谢相关基因,在GBM中识别出神经系统相关基因。
  • 作者认为CoMI有助于分析组学数据并发现疾病基因标签。

研究设计与关键结果

  • 研究提出共识互信息(CoMI)方法,用于分析组学数据并发现基因标签。
  • CoMI在多种癌症中识别出细胞生长与死亡相关基因,在LIHC中识别出外源物生物降解与代谢相关基因,在GBM中识别出神经系统相关基因。
  • CoMI识别出50基因标签有效区分GBM患者为高、低风险组(log-rank p=0.006),用于诊断和预后。

证据类型、等级与局限

  • 证据类型:方法学研究(生物信息学方法开发与验证)。
  • 局限:原文未报告局限性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The gene signatures have been considered as a promising early diagnosis and prognostic analysis to identify disease subtypes and to determine subsequent treatments. Tissue-specific gene signatures of a specific disease are an emergency requirement for precision medicine to improve the accuracy and reduce the side effects. Currently, many approaches have been proposed for identifying gene signatures for diagnosis and prognostic. However, they often lack of tissue-specific gene signatures.

RESULTS: Here, we propose a new method, consensus mutual information (CoMI) for analyzing omics data and discovering gene signatures. CoMI can identify differentially expressed genes in multiple cancer omics data for reflecting both cancer-related and tissue-specific signatures, such as Cell growth and death in multiple cancers, Xenobiotics biodegradation and metabolism in LIHC, and Nervous system in GBM. Our method identified 50-gene signatures effectively distinguishing the GBM patients into high- and low-risk groups (log-rank p = 0.006) for diagnosis and prognosis.

CONCLUSIONS: Our results demonstrate that CoMI can identify significant and consistent gene signatures with tissue-specific properties and can predict clinical outcomes for interested diseases. We believe that CoMI is useful for analyzing omics data and discovering gene signatures of diseases.

来源:BMC Bioinformatics,查看原文。版权归原作者所有。

参考来源

  1. Huang SH, Lo YS, Luo YC, et al. CoMI: consensus mutual information for tissue-specific gene signatures. BMC Bioinformatics. 2022. PMID: 35439942. doi:10.1186/s12859-022-04682-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。